Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Determine the proportion of patients with endometriosis unresponsive to medical therapy and to compare the clinical and ultrasonographic characteristics of this group of patients (study group) with the clinical and ultrasonographic characteristics of patients responsive to medical therapy (control group).
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:
• age between 18 and 50 years;
• patients with endometriosis-related pain symptoms (dyspareunia, dyschezia, dysmenorrhea, chronic pelvic pain, dysuria, periovulatory pain, with at least one of these symptoms presenting Numerical Pain Rating Scale intensity \> 5);
• indication for administration of oral hormonal medical treatment for endometriosis;
• acquisition of informed consent.
Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola
RECRUITING
Bologna
Contact Information
Primary
Alessandro Arena
alessandro.arena6@unibo.it
+390512144385
Time Frame
Start Date: 2024-04-19
Estimated Completion Date: 2029-11-28
Participants
Target number of participants: 250
Treatments
Focus group
non-responsive patients to medical treatment
Control group
responsive patients to medical treatment
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna